Bhingarkar, A., Wang, Y., Hoshitsuki, K., Eichinger, K. M., Eichinger, K. M., Rathod, S., . . . Fernandez, C. A. Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity. Frontiers Media S.A.
Chicago Style (17th ed.) CitationBhingarkar, Aboli, et al. Duvelisib Is a Novel NFAT Inhibitor That Mitigates Adalimumab-induced Immunogenicity. Frontiers Media S.A.
MLA (9th ed.) CitationBhingarkar, Aboli, et al. Duvelisib Is a Novel NFAT Inhibitor That Mitigates Adalimumab-induced Immunogenicity. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.